ertugliflozin 5 MG / sitagliptin 100 MG Oral Tablet [Steglujan]
RxNorm concept 1992837, branded drug (sbd). Prescribable name: Steglujan 5 MG / 100 MG Oral Tablet.
- RxCUI
- 1992837
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1992837 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Steglujan 5/100 (ertugliflozin 5 MG / SITagliptin 100 MG ) Oral Tablet; Steglujan 5/100 (ertugliflozin 5 MG / sitagliptin 100 MG ) Oral Tablet; Steglujan 5/100 Oral Tablet; ertugliflozin 5 MG / SITagliptin 100 MG Oral Tablet [Steglujan]
Related concepts
- sitagliptin 100 MG (SCDC, consists of)
- ertugliflozin 5 MG (SCDC, consists of)
- ertugliflozin 5 MG / sitagliptin 100 MG [Steglujan] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Steglujan (BN, has ingredient)
- ertugliflozin 5 MG / sitagliptin 100 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1992837 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1992837 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1992837. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.